Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.

@article{Farhat2010ChangesII,
  title={Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.},
  author={Ghada Nadim Farhat and Rod Walker and Diana S. M. Buist and Tracy Onega and Karla Kerlikowske},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2010},
  volume={28 35},
  pages={5140-6}
}
PURPOSE To assess trends in invasive breast cancer and ductal carcinoma in situ (DCIS) incidence in association with changes in hormone therapy (HT) use in regular mammography screeners. METHODS We included 2,071,814 screening mammography examinations performed between January 1997 and December 2006 on 696,385 women age 40 to 79 years; 9,586 breast cancers were diagnosed within 12 months of a screening examination. We calculated adjusted annual rates (mammogram level) for prevalent HT use… CONTINUE READING